Literature DB >> 31632440

Comprehensive RNA-Seq Data Analysis Identifies Key mRNAs and lncRNAs in Atrial Fibrillation.

Dong-Mei Wu1,2, Zheng-Kun Zhou2, Shao-Hua Fan1,2, Zi-Hui Zheng3, Xin Wen1,2, Xin-Rui Han1,2, Shan Wang1,2, Yong-Jian Wang1,2, Zi-Feng Zhang1,2, Qun Shan1,2, Meng-Qiu Li1,2, Bin Hu1,2, Jun Lu1,2, Gui-Quan Chen4, Xiao-Wu Hong5, Yuan-Lin Zheng1,2.   

Abstract

Long non-coding RNAs (lncRNAs) are an emerging class of RNA species that may play a critical regulatory role in gene expression. However, the association between lncRNAs and atrial fibrillation (AF) is still not fully understood. In this study, we used RNA sequencing data to identify and quantify the both protein coding genes (PCGs) and lncRNAs. The high enrichment of these up-regulated genes in biological functions concerning response to virus and inflammatory response suggested that chronic viral infection may lead to activated inflammatory pathways, thereby alter the electrophysiology, structure, and autonomic remodeling of the atria. In contrast, the downregulated GO terms were related to the response to saccharides. To identify key lncRNAs involved in AF, we predicted lncRNAs regulating expression of the adjacent PCGs, and characterized biological function of the dysregulated lncRNAs. We found that two lncRNAs, ETF1P2, and AP001053.11, could interact with protein-coding genes (PCGs), which were implicated in AF. In conclusion, we identified key PCGs and lncRNAs, which may be implicated in AF, which not only improves our understanding of the roles of lncRNAs in AF, but also provides potentially functional lncRNAs for AF researchers.
Copyright © 2019 Wu, Zhou, Fan, Zheng, Wen, Han, Wang, Wang, Zhang, Shan, Li, Hu, Lu, Chen, Hong and Zheng.

Entities:  

Keywords:  RNA-Seq; atrial fibrillation; genes; long non-coding RNAs; protein coding genes

Year:  2019        PMID: 31632440      PMCID: PMC6783610          DOI: 10.3389/fgene.2019.00908

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


Introduction

Atrial fibrillation (AF), one of the most common serious arrhythmia worldwide, whose extreme complications such as heart failure and embolic stroke are often of high risks and associated with increasing morbidity and mortality (Conen et al., 2011). Atrial remodeling, both electrical and structural, are important characteristics in AF (Li et al., 2017; Allessie et al., 2002). AF could bring permanent changes such as enlarged left and right atrial size. Moreover, increasing left atrial volume has been stated as a risk factor of cardioembolic stroke, and it is critical to interpret the mechanism behind this to improve the stroke prevention strategy. The etiology of AF has not been fully elucidated as a varying range of factors would contribute to AF, such as family history, unhealthy lifestyle, high blood pressure and other diseases (Shi et al., 2013). With the development of next-generation sequencing technologies, non-coding RNAs (ncRNAs) emerged as the epicenter for researchers to further explore the genetic cause behind AF. ncRNAs, which can be subdivided into small ncRNAs (< 200 nt) and long ncRNAs (lncRNAs), are not translated in proteins, but some of them are capable of regulating various cellular processes such as the expression of certain genes. Evidences have verified that many lncRNAs, often generated from transcriptional units, play a critical role in several cardiovascular diseases (Su et al., 2018), and it is of great importance to survey how they function in AF and how they are connected with atrial remodeling. Several researches are conducted to explore how lncRNAs acted as regulators in atrial electrical remodeling, revealing that TCONS_00075467 may help decrease AF vulnerability through suppressing the electrical remodeling (Li et al., 2017). Recent reports have also unveiled that lncRNAs can act as modulators of miRNA levels in various cardiac diseases (Greco et al., 2018). Also, inflammation and AF are confirmed to have a close relationship. Abundant inflammatory markers and higher ratios of neutrophil and lymphocyte are often observed in patients with AF (Hu et al., 2015), and AF subsequently triggers more inflammatory response, which in turns results in worsened conditions. Exploring active lncRNAs in inflammation would shed light on the prevention, diagnosis, and therapeutic strategies of AF, and help elucidate underlying mechanisms. In the present study, we identified differentially expressed lncRNAs and mRNAs in patients with AF and predicted lncRNA function in a co-expression-based manner. Prediction of cis-acting lncRNAs and functional annotation of dysregulated lncRNAs screened out some critical lncRNAs implicated in AF, which not only improves our understanding of the roles of lncRNAs in AF, but also provides potentially functional lncRNAs for AF researchers. In addition, as evidence proves that a variety of inflammation-associated cytokines and chemokines are involved in the pathogenesis of AF (Schnabel et al., 2009), we further investigate whether our findings are related to cytokines and chemokines in certain aspects.

Materials and Methods

Data Collection

We collected RNA sequencing data of 6 cases with AF and 6 controls from Sequence Read Archive (SRA, https://www.ncbi.nlm.nih.gov/sra) database (Leinonen et al., 2011) with an accession number SRP093226, which was provided by previous study (Yu et al., 2017). We uncompressed the SRA files by fastq-dump with the option –split-files, which generated two paired fastq files.

Read Mapping and Gene Expression Quantification

For each sample, we first mapped the RNA-seq reads to UCSC hg19 human reference genome (www.genome.ucsc.edu) using hisat2 (Kim et al., 2015), and then sorted the SAM files by samtools. With the gene annotation from GENCODE v19 (Harrow et al., 2012), the gene expression was estimated by the StringTie (Pertea et al., 2015) and ballgown pipeline. We considered genes with biotypes, including ‘processed_transcript’, ‘pseudogene’, ‘lincRNA’, ‘3prime_overlapping_ncrna’, ‘antisense’, ‘sense_intronic’, and ‘sense_overlapping’, as lncRNAs.

Differential Expression Analysis

The FPKM-based expression was used to identify differentially expressed genes. The gene expression values were first transformed to log2 (FPKM + 1), and then tested for differential expression by t test. The differentially expressed genes were identified with the thresholds of P-value <0.05 and fold change >2 or <1/2.

Gene Ontology Enrichment Analysis

The Gene Ontology (GO) enrichment analysis was implemented in R with clusterProfiler package (Yu et al., 2012), which used overrepresentation enrichment analysis (ORA) to identify enriched GO terms. The GO terms were deemed to be significantly enriched if the adjusted P < 0.05 and the gene count in each GO term was more than 3.

Functional Annotation of lncRNAs

The biological function of lncRNAs was annotated by overrepresentation enrichment analysis (ORA) of co-expressed protein-coding genes (PCGs). The PCGs were defined as co-expressed genes with a given lncRNA if the P < 0.0001 for the correlation coefficient test.

Identification of Cis-Acting lncRNAs

As the lncRNAs may regulate the expression levels of the corresponding adjacent PCGs by cis-acting manner, the cis-acting lncRNAs were identified if the lncRNA and its adjacent PCGs (within one million base pairs) exhibit highly correlated expression (Pearson correlation coefficient > 0.5 or < −0.5).

Results

RNA Sequencing Method Reveals Diverse RNAs in Both AF and Control Groups

The analysis of sequencing data with 6 AF patients and 6 controls allowed us to identify 15,147 genes in total (FPKM > 1 in at least one sample), which consisted of 29 RNA categories, including protein-coding genes (PCGs), pseudogenes, antisense RNAs and etc. ( ). The PCGs, pseudogenes, and antisense RNAs accounted for about 90% of the total identified RNAs. For each RNA category, the number of genes in AF was not observed to be higher or lower than that in control (Wilcoxon rank-sum test, P < 0.05). In addition, we also considered genes with seven specific biotypes as lncRNAs (See Material and Methods). Given a threshold of FPKM >1 in at least 25% samples (n = 3), we identified 9,233 PCGs, 2,213 lncRNAs, and 961 other ncRNA genes, which were then used for downstream analysis ( ).
Figure 1

The overview of genes identified by RNA sequencing method. (A) The number of genes identified in each sample (FPKM > 1). The Wilcoxon rank-sum test P-values that compare the gene counts in AF with those in normal controls are listed on the left of the heat-map. (B) The pie chart displays the number of genes, including PCGs, lncRNAs, and other ncRNAs.

The overview of genes identified by RNA sequencing method. (A) The number of genes identified in each sample (FPKM > 1). The Wilcoxon rank-sum test P-values that compare the gene counts in AF with those in normal controls are listed on the left of the heat-map. (B) The pie chart displays the number of genes, including PCGs, lncRNAs, and other ncRNAs.

Identification of Dysregulated mRNAs and lncRNAs in AF

Differential expression analysis was conducted to identify dysregulated genes in AF using the gene expression profiles. Specifically, a total of 946 genes, including 327 up- and 619 down-regulated genes, were differentially expressed in AF as compared with the healthy controls (t-test, P < 0.05 and fold change >2 or <1/2, , ). To investigate the distinction of the dysregulated genes between AF and healthy controls, we performed hierarchical clustering analysis of the dysregulated gene expression profiles, and found that the samples with AF could be clearly distinguished from the healthy controls ( ), indicating that gene expression profiles between AF and healthy controls had marked differences. Among the dysregulated genes, the proportion of PCGs was significantly higher in the up-regulated genes than in the down-regulated genes ( , 249/327 vs. 156/619, proportion test, P < 0.0001). In contrast, the proportion of lncRNAs was observed higher in the down-regulated genes than in the up-regulated genes ( , 315/619 vs. 63/327, proportion test, P < 0.0001).
Figure 2

The differentially expressed genes in AF. (A) The volcano plot displays the up-regulated (red dots) and down-regulated (blue dots) genes. (B) The heat-map shows the scaled gene expression of dysregulated genes. (C) The number of PCGs, lncRNAs, and other ncRNAs in up-regulated, down-regulated, and all dysregulated genes. (D) The expression levels of the top-five up-regulated and down-regulated genes in AF and control.

The differentially expressed genes in AF. (A) The volcano plot displays the up-regulated (red dots) and down-regulated (blue dots) genes. (B) The heat-map shows the scaled gene expression of dysregulated genes. (C) The number of PCGs, lncRNAs, and other ncRNAs in up-regulated, down-regulated, and all dysregulated genes. (D) The expression levels of the top-five up-regulated and down-regulated genes in AF and control. Furthermore, we selected the top-five up- and down-regulated genes ( ), and found that the top-five up-regulated genes were all PCGs, while only one down-regulated gene encoded protein. Notably, three of the top-five upregulated genes, GIMAP8, TNFAIP8L2, and RNASEL, were involved in inflammatory response, suggesting that the dysregulation of inflammatory response may be the an important indicator for AF. On the other hand, the PTX3 had an antiangiogenic role, and its downregulation may lead to enhanced angiogenesis. In addition, lncRNAs, HOTAIRM1, RP11-262H14.1, and RP11-84A19.4, have been reported to be dysregulated in AF by previous studies (Yu et al., 2017; Qian et al., 2019). These results indicated that differential expression analysis could uncover some key genes in AF.

Gene Ontology-Based Enrichment Analysis of the Dysregulated Genes

To investigate some key biological functions involved in AF, we performed overrepresentation enrichment analysis (ORA) on the up- and down-regulated genes, respectively. We found that the up-regulated genes were highly enriched in biological functions related to response to virus, such as defense response to virus, response to virus, viral life cycle, regulation of viral process, and regulation of viral life cycle, and related to inflammatory response, such as positive regulation of I-kappaB kinase/NF-kappaB signaling, and regulation of chemotaxis ( , adjusted P < 0.05). These results indicated that chronic viral infection may lead to activated inflammatory pathways, thereby alter the electrophysiology, structure, and autonomic remodeling of the atria (Chiang et al., 2013).
Figure 3

The GO terms enriched by dysregulated genes. The GO terms enriched by up-regulated and down-regulated genes are displayed in (A) and (B), respectively. The more the gene count, the larger size the circle.

The GO terms enriched by dysregulated genes. The GO terms enriched by up-regulated and down-regulated genes are displayed in (A) and (B), respectively. The more the gene count, the larger size the circle. Among the down-regulated GO terms, biological functions related to the response to saccharides ( ), such as response to lipopolysaccharide, response to glucose, response to hexose, response to monosaccharide, and response to carbohydrate were significantly enriched by the down-regulated genes. Notably, the weakened response to glucose in blood may reduce the insulin level, thereby lead to hyperglycemia, which further demonstrate the close association between hyperglycemia and AF (Rigalleau et al., 2002).

Prediction of lncRNAs Regulating Expression of the Adjacent PCGs

It has been widely recognized that lncRNAs could regulate the expression of the adjacent PCGs by cis-acting manner (Kornienko et al., 2013). To identify these cis-acting lncRNAs, we first searched the adjacent dysregulated PCGs within one million base pairs for each dysregulated lncRNA, and found 187 lncRNA-PCG pairs. The expression levels between the lncRNA and its corresponding PCGs were highly correlated ( ). Particularly, the expression levels of about half of the lncRNA-PCG pairs were negatively correlated, indicating that the lncRNAs may suppress the expression of the adjacent PCGs. With a threshold at Pearson correlation coefficient > 0.5 or < −0.5, we identified 71 lncRNA-PCG pairs, composed of 58 PCGs and 63 lncRNAs, with potential regulatory relationship ( ). Among the cis-acting lncRNAs, we found that pseudogene (46%), antisense (34%), and lincRNA (11%) were the major categories ( ).
Figure 4

The cis-acting lncRNA candidates involved in AF. (A) The density of the correlation coefficients between lncRNAs and the corresponding adjacent PCGs. (B) The distribution of RNA biotypes for the cis-acting lnRNA candidates. (C) The correlation coefficients between ETF1P2 and GIMAP2, and between ETF1P2 and GIMAP4.

The cis-acting lncRNA candidates involved in AF. (A) The density of the correlation coefficients between lncRNAs and the corresponding adjacent PCGs. (B) The distribution of RNA biotypes for the cis-acting lnRNA candidates. (C) The correlation coefficients between ETF1P2 and GIMAP2, and between ETF1P2 and GIMAP4. To identify key lncRNAs involved in regulating gene expression, we selected seven lncRNAs, AL021707.2, CTD-2622I13.3, ETF1P2, RP11-4K3__A.5, RP11-95J11.1, ZNF137P, and H2AFZP1, that regulated multiple PCGs. Notably, we found that ETF1P2, a pseudogene locating within 7q36, was negatively correlated with two adjacent PCGs with similar functions, GIMAP2 and GIMAP4 ( ), which participated in the regulation of T helper cell differentiation (Filen et al., 2009), indicating that the pseudogene ETF1P2 may be the upstream regulator of T helper cell differentiation.

Functional Annotation of the Dysregulated lncRNAs by Co-Expressed PCGs

As co-expressed genes are more likely to be co-regulated, sharing similar functions, or involved in similar biological processes (Stuart et al., 2003), we predicted the function of lncRNAs by performing overrepresentation enrichment analysis on the co-expressed PCGs to identify enriched GO terms ( ). We found that a large number of lncRNAs (n > 20) had the biological functions termed transcription corepressor activity, proximal promoter sequence-specific DNA binding, and RNA polymerase II proximal promoter sequence-specific DNA binding ( ). Specifically, 38 lncRNAs were characterized with transcription corepressor activity, and highly correlated with five PCGs (Pearson correlation coefficient > 0.5), SF1, MNT, NR1D1, SKI, DNAJB1, and YY1, with the same GO term ( ). In addition, we also found that one lncRNA, AP001053.11, may participate in inflammatory response related GO terms, such as chemokine binding, chemokine receptor activity, cytokine binding, and cytokine receptor activity ( ). Notably, three chemokine receptor, CX3CR1, CCR2, and CCR5, were highly correlated with AP001053.11 (Pearson correlation coefficient > 0.9), further suggesting a critical role of AP001053.11 in regulation of chemokine receptor activity.
Figure 5

The functional annotation of lncRNAs by co-expressed PCGs. (A) The overview of the GO terms for the annotation of dysregulated lncRNAs (FDR < 0.05). (B) The PCGs and lncRNAs involved in transcription corepressor activity. (C) The correlation coefficients between PCGs and lncRNAs involved in transcription corepressor activity. (D) The scatter plots display the correlation between AP001053.11 and one of three chemokine receptors, including CX3CR1, CCR2, and CCR5.

The functional annotation of lncRNAs by co-expressed PCGs. (A) The overview of the GO terms for the annotation of dysregulated lncRNAs (FDR < 0.05). (B) The PCGs and lncRNAs involved in transcription corepressor activity. (C) The correlation coefficients between PCGs and lncRNAs involved in transcription corepressor activity. (D) The scatter plots display the correlation between AP001053.11 and one of three chemokine receptors, including CX3CR1, CCR2, and CCR5.

Discussion

LncRNAs are an emerging class of RNA species that may play a critical regulatory role in gene expression. LncRNAs can serve as diagnostic biomarkers or therapeutic targets for many diseases (Ishii et al., 2006; Chen et al., 2008; Chubb et al., 2008). However, the association between lncRNAs and AF is still not fully understood. In this study, we used RNA sequencing data to identify and quantify the both PCGs and lncRNAs, and conducted differential expression analysis to identify dysregulated genes in AF. Specifically, a total of 946 genes, including 327 up- and 619 down-regulated genes, were differentially expressed in AF as compared with the healthy controls (t-test, P <0.05 and fold change >2 or <1/2, , ). The hierarchical clustering analysis of those dysregulated gene expression profiles showed that the samples with AF could be clearly distinguished from the healthy controls ( ), indicating that gene expression profiles between AF and healthy controls had marked differences. Furthermore, we found that three of the top-five upregulated genes, GIMAP8, TNFAIP8L2, and RNASEL, were involved in inflammatory response, which was in accordance with the conclusion that the infiltration of immune cells and proteins that mediate inflammatory response in cardiac tissue and circulatory processes is associated with AF by previous studies (Yamashita et al., 2010; Harada et al., 2015). On the other hand, the PTX3 had an antiangiogenic role, and its downregulation may lead to enhanced angiogenesis, which has been reported to be associated with AF (Berntsson et al., 2019). To investigate some key biological functions involved in AF, we performed ORA on the dysregulated genes. The significant enrichment of these up-regulated genes in biological functions related to response to virus and inflammatory response suggested that chronic viral infection may lead to activated inflammatory pathways, thereby alter the electrophysiology, structure, and autonomic remodeling of the atria (Chiang et al., 2013). In contrast, the downregulated GO terms were related to the response to saccharides ( ), which gave us a hint that the weakened response to glucose in blood may reduce the insulin level, thereby lead to hyperglycemia as previous study reported (Rigalleau et al., 2002). To identify key lncRNAs involved in AF, we predicted lncRNA-regulated expression of the adjacent PCGs, and characterized biological function of the dysregulated lncRNAs. We found that ETF1P2, a pseudogene locating within 7q36, was negatively correlated with two adjacent PCGs with similar functions, GIMAP2 and GIMAP4 ( ), which participated in regulation of T helper cell differentiation (Filen et al., 2009), indicating that the pseudogene ETF1P2 may be an upstream regulator of T helper cell differentiation. Moreover, we also found that one lncRNA, AP001053.11, may participate in inflammatory-response-related GO terms by co-expression-based functional annotation. Notably, three chemokine receptor, CX3CR1, CCR2, and CCR5, were highly correlated with AP001053.11 (Pearson correlation coefficient > 0.9), further suggesting that AP001053.11 may be implicated in AF via the regulation of chemokine receptor activity. In addition, there are also some limitations in this study. Firstly, more samples were needed to support our findings about the key lncRNAs. We will collect more samples with AF and healthy donors in the near future, which can overcome this limitation. Secondly, some experimental validation would be required for future verification of the functional lncRNAs. We hope to conduct further research with larger sample size, experimental validation and improved methodology for data analysis in the near future. In conclusion, we have identified key PCGs and lncRNAs, which may be implicated in AF, which not only improves our understanding of the roles of lncRNAs in AF, but also provides potentially functional lncRNAs for AF researchers.

Data Availability Statement

The datasets generated for this study can be found in the SRP093226.

Author Contributions

Conception and design: D-MW, JL, G-QC, X-WH, Y-LZ; Administrative support: JL, G-QC, Y-LZ; Provision of study materials or patients: D-MW, S-HF, Z-HZ; Collection and assembly of data: D-MW, S-HF, XW, X-RH, SW, Y-JW, Z-FZ; Data analysis and interpretation: D-MW, QS, M-QL; Manuscript writing: All authors; Final approval of manuscript: All authors.

Funding

This work was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); the 2016 “333 Project” Award of Jiangsu Province, the 2013 “Qinglan Project” of the Young and Middle-aged Academic Leader of Jiangsu College and University, the National Natural Science Foundation of China (81871249, 81571055, 81400902, 81271225, 81171012, and 30950031), the Major Fundamental Research Program of the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (13KJA180001), and grants from the Cultivate National Science Fund for Distinguished Young Scholars of Jiangsu Normal University.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  26 in total

1.  clusterProfiler: an R package for comparing biological themes among gene clusters.

Authors:  Guangchuang Yu; Li-Gen Wang; Yanyan Han; Qing-Yu He
Journal:  OMICS       Date:  2012-03-28

2.  Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction.

Authors:  Nobuaki Ishii; Kouichi Ozaki; Hiroshi Sato; Hiroya Mizuno; Atsushi Takahashi; Yoshinari Miyamoto; Shiro Ikegawa; Naoyuki Kamatani; Masatsugu Hori; Yusuke Nakamura; Toshihiro Tanaka
Journal:  J Hum Genet       Date:  2006-10-26       Impact factor: 3.172

3.  Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.

Authors:  David Conen; Claudia U Chae; Robert J Glynn; Usha B Tedrow; Brendan M Everett; Julie E Buring; Christine M Albert
Journal:  JAMA       Date:  2011-05-25       Impact factor: 56.272

4.  The long noncoding RNA expression profiles of paroxysmal atrial fibrillation identified by microarray analysis.

Authors:  Ying Su; Long Li; Sheng Zhao; Yunan Yue; Shuixiang Yang
Journal:  Gene       Date:  2017-11-10       Impact factor: 3.688

Review 5.  Long Noncoding RNAs and Cardiac Disease.

Authors:  Simona Greco; Antonio Salgado Somoza; Yvan Devaux; Fabio Martelli
Journal:  Antioxid Redox Signal       Date:  2017-08-30       Impact factor: 8.401

6.  Long noncoding RNAs and novel inflammatory genes determined by RNA sequencing in human lymphocytes are up-regulated in permanent atrial fibrillation.

Authors:  Xue-Jing Yu; Li-Hui Zou; Jun-Hua Jin; Fei Xiao; Li Li; Nan Liu; Jie-Fu Yang; Tong Zou
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

7.  StringTie enables improved reconstruction of a transcriptome from RNA-seq reads.

Authors:  Mihaela Pertea; Geo M Pertea; Corina M Antonescu; Tsung-Cheng Chang; Joshua T Mendell; Steven L Salzberg
Journal:  Nat Biotechnol       Date:  2015-02-18       Impact factor: 54.908

8.  Recruitment of immune cells across atrial endocardium in human atrial fibrillation.

Authors:  Takeshi Yamashita; Akiko Sekiguchi; Yu-ki Iwasaki; Taro Date; Koichi Sagara; Hiroaki Tanabe; Hisayoshi Suma; Hitoshi Sawada; Tadanori Aizawa
Journal:  Circ J       Date:  2009-12-15       Impact factor: 2.993

9.  Atrial fibrillation can cause major hyperglycemia.

Authors:  V Rigalleau; L Baillet; M Hocini; H Gin
Journal:  Diabetes Metab       Date:  2002-06       Impact factor: 6.041

Review 10.  Gene regulation by the act of long non-coding RNA transcription.

Authors:  Aleksandra E Kornienko; Philipp M Guenzl; Denise P Barlow; Florian M Pauler
Journal:  BMC Biol       Date:  2013-05-30       Impact factor: 7.431

View more
  3 in total

1.  RNA-seq-driven expression analysis to investigate cardiovascular disease genes with associated phenotypes among atrial fibrillation patients.

Authors:  Asude Berber; Habiba Abdelhalim; Saman Zeeshan; Sreya Vadapalli; Barr von Oehsen; Naveena Yanamala; Partho Sengupta; Zeeshan Ahmed
Journal:  Clin Transl Med       Date:  2022-07

2.  The presence of cardiotropic viral genomes is not increased in atrial tissue of atrial fibrillation patients.

Authors:  L Wu; R W Emmens; J van Wezenbeek; W Stooker; C P Allaart; A B A Vonk; A C van Rossum; K C Wolthers; H W M Niessen; P A J Krijnen
Journal:  Neth Heart J       Date:  2022-01-31       Impact factor: 2.854

Review 3.  Genetics and Epigenetics of Atrial Fibrillation.

Authors:  Estefanía Lozano-Velasco; Diego Franco; Amelia Aranega; Houria Daimi
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.